262 related articles for article (PubMed ID: 7886572)
21. Prevalence of transfusion associated infections in multitransfused children in relation to mandatory screening of HIV in donated blood.
Aggarwal V; Prakash C; Yadav S; Chattopadhya D
Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):699-706. PubMed ID: 9656388
[TBL] [Abstract][Full Text] [Related]
22. Observation of the changes of plasma proteins after long term plasmapheresis.
Grgicević D; Pistotnik M; Pende B
Dev Biol Stand; 1980; 48():279-86. PubMed ID: 6168506
[TBL] [Abstract][Full Text] [Related]
23. [Donor selection for the production of factor XIII preparations].
Uteg KH; Tausendfreund K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(3):447-55. PubMed ID: 2414175
[TBL] [Abstract][Full Text] [Related]
24. [Subcutaneous administration of desmopressin to plasma donors: a controlled study].
Palacios S; Zuazu I; Candela MJ; Rivera J; Vicente V
Med Clin (Barc); 1995 Oct; 105(14):525-7. PubMed ID: 8523926
[TBL] [Abstract][Full Text] [Related]
25. Fresh frozen plasma in the pediatric pump prime: a prospective, randomized trial.
McCall MM; Blackwell MM; Smyre JT; Sistino JJ; Acsell JR; Dorman BH; Bradley SM
Ann Thorac Surg; 2004 Mar; 77(3):983-7; discussion 987. PubMed ID: 14992912
[TBL] [Abstract][Full Text] [Related]
26. Use of 'single donor' factor VIII from plasma exchange donation.
McLeod BC; Scott JP
JAMA; 1984 Nov; 252(19):2726-9. PubMed ID: 6436520
[TBL] [Abstract][Full Text] [Related]
27. [Possibilities to elevate the factor VIII yield].
Uteg KH; Tausendfreund K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(1):153-69. PubMed ID: 2439416
[TBL] [Abstract][Full Text] [Related]
28. Thrombotic thrombocytopenic purpura in patients with retroviral infection is highly responsive to plasma infusion therapy.
Novitzky N; Thomson J; Abrahams L; du Toit C; McDonald A
Br J Haematol; 2005 Feb; 128(3):373-9. PubMed ID: 15667540
[TBL] [Abstract][Full Text] [Related]
29. Factor VIII collection by pheresis.
McLeod BC; Sassetti RJ; Cole ER; Pierce MI
Lancet; 1980 Sep; 2(8196):671-3. PubMed ID: 6106786
[TBL] [Abstract][Full Text] [Related]
30. The role of commercial plasmapheresis banks on the AIDS epidemic in Mexico.
Volkow P; Perez-Padilla R; del-Rio C; Mohar A
Rev Invest Clin; 1998; 50(3):221-6. PubMed ID: 9763887
[TBL] [Abstract][Full Text] [Related]
31. Properties of a concentrated minipool solvent-detergent treated cryoprecipitate processed in single-use bag systems.
Burnouf T; Caron C; Radosevich M; Goubran HA; Goudemand J; El-Ekiaby M
Haemophilia; 2008 Sep; 14(5):956-62. PubMed ID: 18565126
[TBL] [Abstract][Full Text] [Related]
32. Fresh-frozen plasma, pathogen-reduced single-donor plasma or bio-pharmaceutical plasma?
Hellstern P
Transfus Apher Sci; 2008 Aug; 39(1):69-74. PubMed ID: 18583192
[TBL] [Abstract][Full Text] [Related]
33. Risk of HIV infection from blood transfusion in Montreal.
Remis RS; Delage G; Palmer RW
CMAJ; 1997 Aug; 157(4):375-82. PubMed ID: 9275944
[TBL] [Abstract][Full Text] [Related]
34. The influence of donor characteristics and preparation methods on the potency of human cryoprecipitate.
Burka ER; Puffer T; Martinez J
Transfusion; 1975; 15(4):323-8. PubMed ID: 1166505
[TBL] [Abstract][Full Text] [Related]
35. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
[TBL] [Abstract][Full Text] [Related]
36. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
[TBL] [Abstract][Full Text] [Related]
37. Hemophilia treatment. Predicting the long-term risk of HIV exposure by cryoprecipitate.
Evatt B; Austin H; Leon G; Ruiz-Sáez A; de Bosch N
Haemophilia; 2000 Jul; 6 Suppl 1():128-32. PubMed ID: 10982279
[TBL] [Abstract][Full Text] [Related]
38. [The effect of plasmapheresis on IgG and albumin].
Flesland O; Halvorsen R; Solheim BG; Orjasaeter H
Tidsskr Nor Laegeforen; 1990 Jun; 110(15):1936-7. PubMed ID: 2363163
[TBL] [Abstract][Full Text] [Related]
39. Reducing the risk of HIV transmission through blood transfusion by donor self-deferral.
Urwijitaroon Y; Barusrux S; Romphruk A; Puapairoj C; Pakote L
Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):452-6. PubMed ID: 9185252
[TBL] [Abstract][Full Text] [Related]
40. Unappreciated risk factors for transplant patients: HLA antibodies in blood components.
Bray RA; Harris SB; Josephson CD; Hillyer CD; Gebel HM
Hum Immunol; 2004 Mar; 65(3):240-4. PubMed ID: 15041162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
